Medicines prescribed during the study
| Name of Medicines | No. of Children | Percentage |
|---|---|---|
| Calcarea carb | 9 | 21.42 |
| Lycopodium | 5 | 11.90 |
| Natrum mur | 5 | 11.90 |
| Silicea | 4 | 9.52 |
| Nux vomica | 3 | 7.14 |
| Medorrhinum | 3 | 7.14 |
| Calcarea phos | 2 | 4.76 |
| Staphysagria | 2 | 4.76 |
| Sulphur | 2 | 4.76 |
| Hyoscyamus | 2 | 4.76 |
| Stramonium | 2 | 4.76 |
| Tarentula | 1 | 2.38 |
| Baryta carbonicum | 1 | 2.38 |
| Tuberculinum | 1 | 2.38 |
| Total | 42 | |
t-Test: Paired Two Sample for Means
| Variable 1 | Variable 2 | |
|---|---|---|
| Mean | 30.61904762 | 15.5 |
| Variance | 73.16840883 | 16.15853659 |
| Observations | 42 | 42 |
| Pearson Correlation | 0.855461823 | |
| Hypothesized Mean Difference | 0 | |
| Df | 41 | |
| t Stat | 17.74253616 | |
| P(T<=t) one-tail | 3.79802E-21 | |
| t Critical one-tail | 1.682878002 | |
| P(T<=t) two-tail | 7.59604E-21 | |
| t Critical two-tail | 2.01954097 |
Baseline Profile
| Variables | No. of Cases | Percentage | Mean±SD |
|---|---|---|---|
| Gender | |||
| Male | 28 | 66.66 | |
| Female | 14 | 33.33 | |
| Age Group (in years) | 10±1.58 | ||
| 12 | 12 | 28.57 | |
| 11 | 5 | 11.90 | |
| 10 | 11 | 26.19 | |
| 9 | 8 | 19.04 | |
| 8 | 6 | 14.28 | |
| Intensity of Disease | 21±1.41 | ||
| Mild (VAS Score 12–30) | 22 | 52.38 | |
| Moderate (VAS Score 31–50) | 20 | 47.61 |
Anova: Single Factor
| SUMMARY | ||||
|---|---|---|---|---|
| Groups | Count | Sum | Average | Variance |
| Column 1 | 42 | 1286 | 30.6190476 | 73.1684088 |
| Column 2 | 42 | 651 | 15.5 | 16.1585366 |
| ANOVA | ||||
| Source of Variation | Between Groups | Within Groups | Total | |
| SS | 4800.297619 | 3662.404762 | 8462.702381 | |
| Df | 1 | 82 | 83 | |
| MS | 4800.297619 | 44.66347271 | ||
| F | 107.477035 | |||
| P-value | 1.41097E-16 | |||
| F crit | 3.957388322 | |||
Clinical outcome categories of Children Post-Treatment
| Clinical outcome | No. of Children | Percentage |
|---|---|---|
| Marked Improvement | 10 | 23.80 |
| Moderate Improvement | 22 | 52.38 |
| Mild Improvement | 6 | 14.28 |
| No Improvement | 4 | 9.52 |